argenx SE
SWB:1AEA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
argenx SE
SWB:1AEA
|
NL |
|
T
|
TTW PCL
SET:TTW
|
TH |
|
W
|
Wolverine World Wide Inc
F:WW4
|
US |
|
S
|
Shinhan 18th Special Purpose Acquisition Co
KOSDAQ:0129K0
|
KR |
|
J
|
Jaymart Group Holdings PCL
SET:JMART
|
TH |
|
P
|
Phibro Animal Health Corp
F:PB8
|
US |
|
EMV Capital PLC
LSE:EMVC
|
UK |
|
C
|
Corbion NV
F:CSU
|
NL |
|
Arabian Pipes Company SJSC
SAU:2200
|
SA |
|
Jupiter Fund Management PLC
F:4JF
|
UK |
|
T
|
Tianjin Development Holdings Ltd
XMUN:TJN
|
HK |
|
B
|
Bangkok Land PCL
SET:BLAND
|
TH |
|
Erie Indemnity Co
F:EI2
|
US |
|
R
|
Relx PLC
F:RDEB
|
UK |
|
O
|
Omnia Holdings Ltd
JSE:OMN
|
ZA |
|
Nextpower Inc
NASDAQ:NXT
|
US |
|
C
|
China Life Insurance Co Ltd
XMUN:CHL
|
CN |
|
Gefran S.p.a
F:GF7
|
IT |
|
Orthofix Medical Inc
F:OM2
|
US |
|
A
|
Apogee Optocom Co Ltd
TWSE:6426
|
TW |
Intrinsic Value
Is 1AEA undervalued or overvalued?
See the intrinsic value estimate for 
argenx SE and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
1AEA looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with 1AEA’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What argenx Does
argenx is a biotechnology company that develops antibody-based medicines for serious autoimmune diseases, where the body attacks its own tissues. Its best-known product is VYVGART, a prescription therapy used by specialist doctors and hospitals to treat certain immune disorders. The company also has a pipeline of follow-on drug candidates built around the same antibody engineering platform.
- Headquarters
- Netherlands NL
- Employees
- 1 863
- IPO date
- Jul 10, 2014
argenx has a narrow economic moat
Patents covering Vyvgart’s active medicine and its uses prevent rivals from freely copying argenx’s main treatment. This protects its profits without shutting out competing medicines such as UCB’s Rystiggo and Johnson & Johnson’s Imaavy.
Read the full moat analysis
Earnings Waterfall
argenx SE
The intrinsic value for argenx SE (1AEA) under the Base Case is hidden EUR.
Compared with the current market price of 780 EUR, the stock appears hidden.